Cargando…
Characterizing Hepatitis C Virus–Specific CD4(+) T Cells Following Viral‐Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure
BACKGROUND AND AIMS: Induction of functional helper CD4(+) T cells is the hallmark of a protective immune response against hepatitis C virus (HCV), associated with spontaneous viral clearance. Heterologous prime/boost viral vectored vaccination has demonstrated induction of broad and polyfunctional...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610807/ https://www.ncbi.nlm.nih.gov/pubmed/32012325 http://dx.doi.org/10.1002/hep.31160 |
_version_ | 1783605234680987648 |
---|---|
author | Hartnell, Felicity Esposito, Ilaria Swadling, Leo Brown, Anthony Phetsouphanh, Chansavath de Lara, Catherine Gentile, Chiara Turner, Bethany Dorrell, Lucy Capone, Stefania Folgori, Antonella Barnes, Eleanor Klenerman, Paul |
author_facet | Hartnell, Felicity Esposito, Ilaria Swadling, Leo Brown, Anthony Phetsouphanh, Chansavath de Lara, Catherine Gentile, Chiara Turner, Bethany Dorrell, Lucy Capone, Stefania Folgori, Antonella Barnes, Eleanor Klenerman, Paul |
author_sort | Hartnell, Felicity |
collection | PubMed |
description | BACKGROUND AND AIMS: Induction of functional helper CD4(+) T cells is the hallmark of a protective immune response against hepatitis C virus (HCV), associated with spontaneous viral clearance. Heterologous prime/boost viral vectored vaccination has demonstrated induction of broad and polyfunctional HCV‐specific CD8(+) T cells in healthy volunteers; however, much less is known about CD4(+) T‐cell subsets following vaccination. APPROACH AND RESULTS: We analyzed HCV‐specific CD4(+) T‐cell populations using major histocompatibility complex class II tetramers in volunteers undergoing HCV vaccination with recombinant HCV adenoviral/modified vaccinia Ankara viral vectors. Peptide‐specific T‐cell responses were tracked over time, and functional (proliferation and cytokine secretion) and phenotypic (cell surface and intranuclear) markers were assessed using flow cytometry. These were compared to CD4(+) responses in 10 human leukocyte antigen–matched persons with HCV spontaneous resolution and 21 chronically infected patients treated with directly acting antiviral (DAA) therapy. Vaccination induced tetramer‐positive CD4(+) T cells that were highest 1‐4 weeks after boosting (mean, 0.06%). Similar frequencies were obtained for those tracked following spontaneous resolution of disease (mean, 0.04%). In addition, the cell‐surface phenotype (CD28, CD127) memory subset markers and intranuclear transcription factors, as well as functional capacity of peptide‐specific CD4(+) T‐cell responses characterized after vaccination, are comparable to those following spontaneous viral resolution. In contrast, helper responses in chronic infection were infrequently detected and poorly functional and did not consistently recover following HCV cure. CONCLUSIONS: Helper CD4(+) T‐cell phenotype and function following HCV viral vectored vaccination resembles “protective memory” that is observed following spontaneous clearance of HCV. DAA cure does not promote resurrection of exhausted CD4(+) T‐cell memory in chronic infection. |
format | Online Article Text |
id | pubmed-7610807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76108072021-05-19 Characterizing Hepatitis C Virus–Specific CD4(+) T Cells Following Viral‐Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure Hartnell, Felicity Esposito, Ilaria Swadling, Leo Brown, Anthony Phetsouphanh, Chansavath de Lara, Catherine Gentile, Chiara Turner, Bethany Dorrell, Lucy Capone, Stefania Folgori, Antonella Barnes, Eleanor Klenerman, Paul Hepatology Original Articles BACKGROUND AND AIMS: Induction of functional helper CD4(+) T cells is the hallmark of a protective immune response against hepatitis C virus (HCV), associated with spontaneous viral clearance. Heterologous prime/boost viral vectored vaccination has demonstrated induction of broad and polyfunctional HCV‐specific CD8(+) T cells in healthy volunteers; however, much less is known about CD4(+) T‐cell subsets following vaccination. APPROACH AND RESULTS: We analyzed HCV‐specific CD4(+) T‐cell populations using major histocompatibility complex class II tetramers in volunteers undergoing HCV vaccination with recombinant HCV adenoviral/modified vaccinia Ankara viral vectors. Peptide‐specific T‐cell responses were tracked over time, and functional (proliferation and cytokine secretion) and phenotypic (cell surface and intranuclear) markers were assessed using flow cytometry. These were compared to CD4(+) responses in 10 human leukocyte antigen–matched persons with HCV spontaneous resolution and 21 chronically infected patients treated with directly acting antiviral (DAA) therapy. Vaccination induced tetramer‐positive CD4(+) T cells that were highest 1‐4 weeks after boosting (mean, 0.06%). Similar frequencies were obtained for those tracked following spontaneous resolution of disease (mean, 0.04%). In addition, the cell‐surface phenotype (CD28, CD127) memory subset markers and intranuclear transcription factors, as well as functional capacity of peptide‐specific CD4(+) T‐cell responses characterized after vaccination, are comparable to those following spontaneous viral resolution. In contrast, helper responses in chronic infection were infrequently detected and poorly functional and did not consistently recover following HCV cure. CONCLUSIONS: Helper CD4(+) T‐cell phenotype and function following HCV viral vectored vaccination resembles “protective memory” that is observed following spontaneous clearance of HCV. DAA cure does not promote resurrection of exhausted CD4(+) T‐cell memory in chronic infection. John Wiley and Sons Inc. 2020-11-06 2020-11 /pmc/articles/PMC7610807/ /pubmed/32012325 http://dx.doi.org/10.1002/hep.31160 Text en © 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Hartnell, Felicity Esposito, Ilaria Swadling, Leo Brown, Anthony Phetsouphanh, Chansavath de Lara, Catherine Gentile, Chiara Turner, Bethany Dorrell, Lucy Capone, Stefania Folgori, Antonella Barnes, Eleanor Klenerman, Paul Characterizing Hepatitis C Virus–Specific CD4(+) T Cells Following Viral‐Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure |
title | Characterizing Hepatitis C Virus–Specific CD4(+) T Cells Following Viral‐Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure |
title_full | Characterizing Hepatitis C Virus–Specific CD4(+) T Cells Following Viral‐Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure |
title_fullStr | Characterizing Hepatitis C Virus–Specific CD4(+) T Cells Following Viral‐Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure |
title_full_unstemmed | Characterizing Hepatitis C Virus–Specific CD4(+) T Cells Following Viral‐Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure |
title_short | Characterizing Hepatitis C Virus–Specific CD4(+) T Cells Following Viral‐Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure |
title_sort | characterizing hepatitis c virus–specific cd4(+) t cells following viral‐vectored vaccination, directly acting antivirals, and spontaneous viral cure |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610807/ https://www.ncbi.nlm.nih.gov/pubmed/32012325 http://dx.doi.org/10.1002/hep.31160 |
work_keys_str_mv | AT hartnellfelicity characterizinghepatitiscvirusspecificcd4tcellsfollowingviralvectoredvaccinationdirectlyactingantiviralsandspontaneousviralcure AT espositoilaria characterizinghepatitiscvirusspecificcd4tcellsfollowingviralvectoredvaccinationdirectlyactingantiviralsandspontaneousviralcure AT swadlingleo characterizinghepatitiscvirusspecificcd4tcellsfollowingviralvectoredvaccinationdirectlyactingantiviralsandspontaneousviralcure AT brownanthony characterizinghepatitiscvirusspecificcd4tcellsfollowingviralvectoredvaccinationdirectlyactingantiviralsandspontaneousviralcure AT phetsouphanhchansavath characterizinghepatitiscvirusspecificcd4tcellsfollowingviralvectoredvaccinationdirectlyactingantiviralsandspontaneousviralcure AT delaracatherine characterizinghepatitiscvirusspecificcd4tcellsfollowingviralvectoredvaccinationdirectlyactingantiviralsandspontaneousviralcure AT gentilechiara characterizinghepatitiscvirusspecificcd4tcellsfollowingviralvectoredvaccinationdirectlyactingantiviralsandspontaneousviralcure AT turnerbethany characterizinghepatitiscvirusspecificcd4tcellsfollowingviralvectoredvaccinationdirectlyactingantiviralsandspontaneousviralcure AT dorrelllucy characterizinghepatitiscvirusspecificcd4tcellsfollowingviralvectoredvaccinationdirectlyactingantiviralsandspontaneousviralcure AT caponestefania characterizinghepatitiscvirusspecificcd4tcellsfollowingviralvectoredvaccinationdirectlyactingantiviralsandspontaneousviralcure AT folgoriantonella characterizinghepatitiscvirusspecificcd4tcellsfollowingviralvectoredvaccinationdirectlyactingantiviralsandspontaneousviralcure AT barneseleanor characterizinghepatitiscvirusspecificcd4tcellsfollowingviralvectoredvaccinationdirectlyactingantiviralsandspontaneousviralcure AT klenermanpaul characterizinghepatitiscvirusspecificcd4tcellsfollowingviralvectoredvaccinationdirectlyactingantiviralsandspontaneousviralcure |